226 related articles for article (PubMed ID: 19668228)
1. Plk1 regulates liver tumor cell death by phosphorylation of TAp63.
Komatsu S; Takenobu H; Ozaki T; Ando K; Koida N; Suenaga Y; Ichikawa T; Hishiki T; Chiba T; Iwama A; Yoshida H; Ohnuma N; Nakagawara A; Kamijo T
Oncogene; 2009 Oct; 28(41):3631-41. PubMed ID: 19668228
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional activity of TAp63 promoter is regulated by c-jun.
Yao JY; Pao CC; Chen JK
J Cell Physiol; 2010 Nov; 225(3):898-904. PubMed ID: 20607803
[TBL] [Abstract][Full Text] [Related]
3. Suppression of Polo like kinase 1 (PLK1) by p21(Waf1) mediates the p53-dependent prevention of caspase-independent mitotic death.
Lin YC; Sun SH; Wang FF
Cell Signal; 2011 Nov; 23(11):1816-23. PubMed ID: 21726628
[TBL] [Abstract][Full Text] [Related]
4. Genistein-induced neuronal apoptosis and G2/M cell cycle arrest is associated with MDC1 up-regulation and PLK1 down-regulation.
Ismail IA; Kang KS; Lee HA; Kim JW; Sohn YK
Eur J Pharmacol; 2007 Dec; 575(1-3):12-20. PubMed ID: 17706963
[TBL] [Abstract][Full Text] [Related]
5. TAp63 plays compensatory roles in p53-deficient cancer cells under genotoxic stress.
Yao JY; Chen JK
Biochem Biophys Res Commun; 2010 Dec; 403(3-4):310-5. PubMed ID: 21075072
[TBL] [Abstract][Full Text] [Related]
6. Plk1-mediated mitotic phosphorylation of PinX1 regulates its stability.
Wang C; Yu J; Yuan K; Lan J; Jin C; Huang H
Eur J Cell Biol; 2010 Oct; 89(10):748-56. PubMed ID: 20573420
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory role of Plk1 in the regulation of p73-dependent apoptosis through physical interaction and phosphorylation.
Koida N; Ozaki T; Yamamoto H; Ono S; Koda T; Ando K; Okoshi R; Kamijo T; Omura K; Nakagawara A
J Biol Chem; 2008 Mar; 283(13):8555-63. PubMed ID: 18174154
[TBL] [Abstract][Full Text] [Related]
8. P21-activated kinase is required for mitotic progression and regulates Plk1.
Maroto B; Ye MB; von Lohneysen K; Schnelzer A; Knaus UG
Oncogene; 2008 Aug; 27(36):4900-8. PubMed ID: 18427546
[TBL] [Abstract][Full Text] [Related]
9. Polo-like kinase 1 regulates mitotic arrest after UV irradiation through dephosphorylation of p53 and inducing p53 degradation.
Chen J; Dai G; Wang YQ; Wang S; Pan FY; Xue B; Zhao DH; Li CJ
FEBS Lett; 2006 Jun; 580(15):3624-30. PubMed ID: 16753148
[TBL] [Abstract][Full Text] [Related]
10. The expression of TA and DeltaNp63 are regulated by different mechanisms in liver cells.
Petitjean A; Cavard C; Shi H; Tribollet V; Hainaut P; Caron de Fromentel C
Oncogene; 2005 Jan; 24(3):512-9. PubMed ID: 15543231
[TBL] [Abstract][Full Text] [Related]
11. Cancer Osaka thyroid (Cot) phosphorylates Polo-like kinase (PLK1) at Ser137 but not at Thr210.
Wu B; Jiang P; Mu Y; Wilmouth RC
Biol Chem; 2009 Dec; 390(12):1271-7. PubMed ID: 19804365
[TBL] [Abstract][Full Text] [Related]
12. Hamartin, the tuberous sclerosis complex 1 gene product, interacts with polo-like kinase 1 in a phosphorylation-dependent manner.
Astrinidis A; Senapedis W; Henske EP
Hum Mol Genet; 2006 Jan; 15(2):287-97. PubMed ID: 16339216
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation by polo-like kinase 1 induces the tumor-suppressing activity of FADD.
Jang MS; Lee SJ; Kim CJ; Lee CW; Kim E
Oncogene; 2011 Jan; 30(4):471-81. PubMed ID: 20890306
[TBL] [Abstract][Full Text] [Related]
14. Polo-like kinase 1 phosphorylates and regulates Bcl-x(L) during pironetin-induced apoptosis.
Tamura Y; Simizu S; Muroi M; Takagi S; Kawatani M; Watanabe N; Osada H
Oncogene; 2009 Jan; 28(1):107-16. PubMed ID: 18820703
[TBL] [Abstract][Full Text] [Related]
15. Polo-like kinase 1 inhibition kills glioblastoma multiforme brain tumor cells in part through loss of SOX2 and delays tumor progression in mice.
Lee C; Fotovati A; Triscott J; Chen J; Venugopal C; Singhal A; Dunham C; Kerr JM; Verreault M; Yip S; Wakimoto H; Jones C; Jayanthan A; Narendran A; Singh SK; Dunn SE
Stem Cells; 2012 Jun; 30(6):1064-75. PubMed ID: 22415968
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of heat shock protein 90 function by 17-allylamino-17-demethoxy-geldanamycin in Hodgkin's lymphoma cells down-regulates Akt kinase, dephosphorylates extracellular signal-regulated kinase, and induces cell cycle arrest and cell death.
Georgakis GV; Li Y; Rassidakis GZ; Martinez-Valdez H; Medeiros LJ; Younes A
Clin Cancer Res; 2006 Jan; 12(2):584-90. PubMed ID: 16428504
[TBL] [Abstract][Full Text] [Related]
17. Aberrant Polo-like kinase 1-Cdc25A pathway in metastatic hepatocellular carcinoma.
Wang XQ; Zhu YQ; Lui KS; Cai Q; Lu P; Poon RT
Clin Cancer Res; 2008 Nov; 14(21):6813-20. PubMed ID: 18980975
[TBL] [Abstract][Full Text] [Related]
18. Arecoline-induced phosphorylated p53 and p21(WAF1) protein expression is dependent on ATM/ATR and phosphatidylinositol-3-kinase in clone-9 cells.
Chou WW; Guh JY; Tsai JF; Hwang CC; Chiou SJ; Chuang LY
J Cell Biochem; 2009 Jun; 107(3):408-17. PubMed ID: 19343784
[TBL] [Abstract][Full Text] [Related]
19. Indirect p53-dependent transcriptional repression of Survivin, CDC25C, and PLK1 genes requires the cyclin-dependent kinase inhibitor p21/CDKN1A and CDE/CHR promoter sites binding the DREAM complex.
Fischer M; Quaas M; Nickel A; Engeland K
Oncotarget; 2015 Dec; 6(39):41402-17. PubMed ID: 26595675
[TBL] [Abstract][Full Text] [Related]
20. Long-term downregulation of Polo-like kinase 1 increases the cyclin-dependent kinase inhibitor p21(WAF1/CIP1).
Kreis NN; Sommer K; Sanhaji M; Krämer A; Matthess Y; Kaufmann M; Strebhardt K; Yuan J
Cell Cycle; 2009 Feb; 8(3):460-72. PubMed ID: 19177004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]